$LFST

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (1w)

+2.7%

Win rate (1w)

0% (2 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$LFSTSEC Form 4bearish

Paunovich Vukasin · Chief Technology Officer at LifeStance Health Group, Inc. · 26d agono track record yet

Sold 42,067 @ $12.87 avg · $541,402 · 2026-09-02

Form 4: Paunovich Vukasin sold LFST

Paunovich Vukasin (Chief Technology Officer at LifeStance Health Group, Inc.) reported an open-market sale of 42,067 shares of LFST at an average $12.87, roughly $541,402, in a Form 4 filed 2026-09-04.

At post $12.73Now $12.57-1.3% since postedas of Sep 18, 4:30 PM ET

1d—

3d—

1w+1.9%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$LFSTSEC Form 4bearish

Burdick Kenneth A · LifeStance Health Group, Inc. · 48d agono track record yet

Sold 500,000 @ $11.51 avg · $5,755,000 · 2026-08-11

Form 4: Burdick Kenneth A sold LFST

Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 500,000 shares of LFST at an average $11.51, roughly $5,755,000, in a Form 4 filed 2026-08-13.

At post $12.22Now $12.57+2.9% since postedas of Sep 18, 4:30 PM ET

1d+1.6%

3d+1.6%

1w+3.5%

1m+6.1%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.